skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer

Authors:
 [1];  [2];  [2];  [2];  [2];  [3];  [1];  [2]
  1. Departments of Biochemistry, Chemistry, and Pharmacology, Vanderbilt Institute of Chemical Biology, Center in Molecular Toxicology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146, United States
  2. Department of Pharmacology and Center of Excellence in Environmental Toxicology, Perelman School of Medicine, University of Pennsylvania, 1315 BRB II/III, 420 Curie Boulevard, Philadelphia, Pennsylvania 19104-6061, United States
  3. Department of Chemistry, University of Pennsylvania, 231 South 34th Street, Philadelphia, Pennsylvania 19104-6323, United States
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1123359
Resource Type:
Published Article
Journal Name:
Journal of Medicinal Chemistry
Additional Journal Information:
Journal Name: Journal of Medicinal Chemistry Journal Volume: 56 Journal Issue: 6; Journal ID: ISSN 0022-2623
Publisher:
American Chemical Society
Country of Publication:
United States
Language:
English

Citation Formats

Liedtke, Andy J., Adeniji, Adegoke O., Chen, Mo, Byrns, Michael C., Jin, Yi, Christianson, David W., Marnett, Lawrence J., and Penning, Trevor M. Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer. United States: N. p., 2013. Web. doi:10.1021/jm3017656.
Liedtke, Andy J., Adeniji, Adegoke O., Chen, Mo, Byrns, Michael C., Jin, Yi, Christianson, David W., Marnett, Lawrence J., & Penning, Trevor M. Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer. United States. doi:10.1021/jm3017656.
Liedtke, Andy J., Adeniji, Adegoke O., Chen, Mo, Byrns, Michael C., Jin, Yi, Christianson, David W., Marnett, Lawrence J., and Penning, Trevor M. Thu . "Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer". United States. doi:10.1021/jm3017656.
@article{osti_1123359,
title = {Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer},
author = {Liedtke, Andy J. and Adeniji, Adegoke O. and Chen, Mo and Byrns, Michael C. and Jin, Yi and Christianson, David W. and Marnett, Lawrence J. and Penning, Trevor M.},
abstractNote = {},
doi = {10.1021/jm3017656},
journal = {Journal of Medicinal Chemistry},
number = 6,
volume = 56,
place = {United States},
year = {2013},
month = {3}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record
DOI: 10.1021/jm3017656

Citation Metrics:
Cited by: 33 works
Citation information provided by
Web of Science

Save / Share: